Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Davy James, Associate Editorial Director
Articles
Lauren Meyer, PharmD, MSBPA;Jennifer Barrett, Associate Editor;Davy James, Associate Editorial Director
October 27th 2019Dupixent is the first FDA-approved medicine for adults with chronic rhinosinusitis with nasal polyposis and the only approved therapy shown to shrink nasal polyp size and improve the signs and symptoms of the associated chronic rhinosinusitis.
Read More
Latest Updated Articles
Published: March 10th 2025 | Updated: March 21st 2025
Pharmacists Will Play an Essential Role in Optimizing Vutrisiran Therapy for ATTR-CM
Published: March 12th 2025 | Updated: March 18th 2025
MDMA Rejected: The Story of a Study Participant Entrenched in Ethical Violations
Published: February 26th 2025 | Updated: March 14th 2025
Navigating Steroid-Refractory GVHD Treatment: A Pharmacist’s Guide to Medication Management
Published: March 7th 2025 | Updated: March 10th 2025
FDA Approves Interchangeable Biosimilar to Xolair
Published: January 22nd 2025 | Updated: January 28th 2025
Reversal of Executive Order 14087 Raises Questions About Future Drug Pricing Reforms
Published: December 18th 2024 | Updated: January 2nd 2025
Study Shows Choline and Iodine Are Missing Links in Prenatal Supplements
